STOCK TITAN

High Tide Announces Preliminary Q3 2025 Guidance

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

High Tide Inc. (NASDAQ: HITI) has released preliminary guidance for Q3 2025, projecting record-breaking performance. The company expects revenue between $147-150 million, representing 7-9% sequential and 12-14% year-over-year growth, surpassing analyst consensus of $146 million.

The cannabis retailer anticipates Adjusted EBITDA of $9.6-10.6 million, showing 19-31% sequential growth and up to 10% year-over-year increase, significantly above analyst expectations of $8.4 million. Same-store sales growth reached a two-year high of 7.4%. The company also highlighted its recent expansion into Germany through the acquisition of Remexian Pharma GmbH.

High Tide will release full Q3 2025 results on September 15, 2025, after market close, with a conference call scheduled for the following morning.

High Tide Inc. (NASDAQ: HITI) ha pubblicato una guida preliminare per il terzo trimestre 2025, prevedendo risultati da record. La società stima ricavi tra $147-150 milioni, pari a una crescita sequenziale del 7-9% e del 12-14% su base annua, superando il consenso degli analisti fissato a $146 milioni.

Il rivenditore di cannabis prevede un Adjusted EBITDA di $9,6-10,6 milioni, con un aumento sequenziale del 19-31% e fino al 10% su base annua, ben oltre le attese degli analisti di $8,4 milioni. La crescita delle vendite same-store ha raggiunto un massimo biennale del 7,4%. La società ha inoltre rimarcato l'espansione recente in Germania con l'acquisizione di Remexian Pharma GmbH.

High Tide pubblicherà i risultati completi del Q3 2025 il 15 settembre 2025, dopo la chiusura del mercato, con conference call programmata per la mattina successiva.

High Tide Inc. (NASDAQ: HITI) presentó una guía preliminar para el tercer trimestre de 2025, proyectando un desempeño récord. La compañía espera ingresos entre $147-150 millones, lo que supone un crecimiento secuencial del 7-9% y del 12-14% interanual, superando el consenso de analistas de $146 millones.

El minorista de cannabis anticipa un EBITDA ajustado de $9.6-10.6 millones, con un aumento secuencial del 19-31% y hasta un 10% interanual, muy por encima de las expectativas de los analistas de $8.4 millones. El crecimiento de ventas en tiendas comparables alcanzó un máximo de dos años del 7.4%. La compañía también destacó su reciente expansión en Alemania mediante la adquisición de Remexian Pharma GmbH.

High Tide publicará los resultados completos del Q3 2025 el 15 de septiembre de 2025, tras el cierre del mercado, y celebrará una conferencia telefónica a la mañana siguiente.

High Tide Inc. (NASDAQ: HITI)는 2025년 3분기 예비 가이던스를 발표하며 사상 최대 실적을 예상했습니다. 회사는 매출을 $147-150백만으로 전망했으며, 이는 전분기 대비 7~9%, 전년 동기 대비 12~14% 증가한 수치로 애널리스트 컨센서스인 $146백만을 상회합니다.

이 대마초 소매업체는 조정 EBITDA를 $9.6-10.6백만으로 예상하며 전분기 대비 19~31% 증가하고 전년 대비 최대 10% 상승할 것으로 전망해 애널리스트 예상치 $8.4백만을 크게 웃돌았습니다. 동일 점포 매출 성장률은 2년 만에 최고치인 7.4%를 기록했습니다. 회사는 또한 Remexian Pharma GmbH 인수를 통한 독일 시장 진출을 강조했습니다.

High Tide는 전체 2025년 3분기 실적을 2025년 9월 15일 장 마감 후 발표하고, 다음 날 아침 컨퍼런스 콜을 진행할 예정입니다.

High Tide Inc. (NASDAQ: HITI) a publié des indications préliminaires pour le troisième trimestre 2025, anticipant des performances record. La société prévoit un chiffre d'affaires compris entre 147 et 150 millions $, soit une progression séquentielle de 7 à 9% et de 12 à 14% en glissement annuel, dépassant le consensus des analystes à 146 millions $.

Le détaillant de cannabis anticipe un EBITDA ajusté de 9,6 à 10,6 millions $, en hausse séquentielle de 19 à 31% et jusqu'à 10% en glissement annuel, nettement au‑dessus des attentes des analystes de 8,4 millions $. La croissance des ventes en magasins comparables a atteint un plus haut sur deux ans de 7,4%. La société a également souligné son expansion récente en Allemagne via l'acquisition de Remexian Pharma GmbH.

High Tide publiera les résultats complets du T3 2025 le 15 septembre 2025, après la clôture des marchés, avec une conférence téléphonique programmée le lendemain matin.

High Tide Inc. (NASDAQ: HITI) hat vorläufige Prognosen für das dritte Quartal 2025 veröffentlicht und erwartet Rekordergebnisse. Das Unternehmen rechnet mit einem Umsatz von $147–150 Millionen, was einem sequenziellen Wachstum von 7–9% und einem Jahreswachstum von 12–14% entspricht und damit den Analystenkonsens von $146 Millionen übertrifft.

Der Cannabis-Einzelhändler erwartet ein bereinigtes EBITDA von $9,6–10,6 Millionen, was einem sequenziellen Anstieg von 19–31% und einem Jahreszuwachs von bis zu 10% entspricht und deutlich über den Analystenerwartungen von $8,4 Millionen liegt. Das Same-Store-Sales-Wachstum erreichte mit 7,4% ein Zweijahreshoch. Das Unternehmen hob außerdem seine jüngste Expansion nach Deutschland durch die Übernahme von Remexian Pharma GmbH hervor.

High Tide wird die vollständigen Q3-2025-Ergebnisse am 15. September 2025 nach Börsenschluss veröffentlichen; die Telefonkonferenz ist für den folgenden Morgen geplant.

Positive
  • Revenue guidance of $147-150M exceeds analyst consensus of $146M
  • Adjusted EBITDA guidance of $9.6-10.6M represents up to 31% sequential growth
  • Same-store sales growth reached 7.4%, highest in two years
  • Strategic expansion into German market through Remexian Pharma acquisition
  • Operates 203 retail locations across Canada under Canna Cabana brand
Negative
  • Adjusted EBITDA year-over-year growth limited to 0-10%, showing potential margin pressure

Insights

High Tide's Q3 guidance shows impressive growth with revenue, EBITDA, and same-store sales all exceeding expectations, signaling strong operational momentum.

High Tide's preliminary Q3 2025 guidance demonstrates robust financial performance across key metrics. The company expects revenue between $147-150 million, representing 7-9% sequential growth and 12-14% year-over-year growth—notably exceeding analyst consensus of $146 million. More impressive is the projected Adjusted EBITDA of $9.6-10.6 million, showing 19-31% sequential growth and potentially 10% year-over-year improvement, significantly outpacing analyst expectations of $8.4 million.

The 7.4% same-store sales growth is particularly noteworthy as it represents their strongest performance in two years, indicating healthy underlying demand and effective retail execution. This metric is critical for retail businesses as it strips out growth from new store openings and shows organic performance improvements at existing locations. Gross margin is also trending positively at $38.5-40 million, representing 9-13% growth both sequentially and year-over-year.

From a strategic perspective, High Tide is leveraging its established Canadian retail presence (203 Canna Cabana locations) while expanding internationally through the acquisition of a majority stake in Germany's Remexian Pharma GmbH. This international expansion reduces market concentration risk and positions the company to capitalize on emerging opportunities in Europe's cannabis market. Their vertically integrated approach—spanning retail, e-commerce, accessories, and branded products—provides multiple revenue streams and potential operational synergies.

While these preliminary results signal strong operational execution and improving financial health, investors should note these are unaudited figures subject to potential adjustments during the final financial closing procedures. The company's sequential EBITDA growth is particularly meaningful as it demonstrates improving operational efficiency and margin expansion despite the challenging retail environment facing cannabis operators.

The Company Expects Record Revenue, Adjusted EBITDA Ahead of Analyst Forecasts and a Two-Year High in Same-Store Sales Growth

The Company Also Shares Details of Its Q3 2025 Earnings Event

CALGARY, AB, Aug. 18, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to release guidance estimates regarding anticipated results for its third fiscal quarter ended July 31, 2025. 


Management Guidance Range

(Expressed in millions of Canadian Dollars)

Implied Sequential Quarter-over-Quarter Change

Implied Year-over-Year Change

Analyst Expectations1

(Millions of Dollars CAD)


Low

High

Low

High

Low

High

Low

Consensus

High

Revenue

$147.0

$150.0

7 %

9 %

12 %

14 %

$145.8

$146.0

$146.3

Gross Margin

$38.5

$40.0

9 %

13 %

9 %

13 %

$37.7

$38.0

$38.3

Adjusted EBITDA2

$9.6

$10.6

19 %

31 %

0 %

10 %

$8.1

$8.4

$8.6

Notes:

1.

Based on FactSet Reporting as at August 17, 2025; https://www.factset.com.

2.

Adjusted Earnings before interest, taxes, depreciation, and amortization ("EBITDA"). This measure does not have a standardized meaning prescribed by International Financial Reporting Standards ("IFRS") and is, therefore, unlikely to be comparable to similar measures presented by other issuers. Non-IFRS measures provide investors with a supplemental measure of the Company's operating performance and, therefore, highlight trends in the Company's core business that may not otherwise be apparent when relying solely on IFRS measures. Management uses non-IFRS measures in measuring the financial performance of the Company.

"This quarter's guidance showcases the strength and momentum of High Tide like never before. We expect to deliver record revenue and powerful sequential Adjusted EBITDA growth. These results have been fueled by a projected 7.4% increase in same-store sales during the quarter, which was our fastest growth rate in two years," said Raj Grover, Founder and Chief Executive Officer of High Tide. "These results, anticipated to be well above analyst expectations, highlight how underappreciated our core Canadian business remains. With our entry into Germany, through the recently announced acquisition of a majority stake in Remexian Pharma GmbH, we're no longer just a Canadian success story—we're building the next global cannabis powerhouse."

The Company anticipates releasing full financial and operational results for the third fiscal quarter ended July 31, 2025 on Monday, September 15, 2025, after markets close, with a conference call the following morning.

WEBCAST LINK FOR HIGH TIDE EARNINGS EVENT

The Company will host a webcast and conference call to discuss its audited results and outlook at 11:30 AM (Eastern Time) on Tuesday, September 16, 2025.

https://app.webinar.net/6NDyqVDQLzX

Participants are encouraged to pre-register for the webcast by clicking on the link above prior to the beginning of the live webcast. Three hours after the live webcast, a replay of the webcast will be available at the same link above.

Participants who wish to ask questions during the event may do so through the call-in line, the access information for which is as follows:

North American Toll Free: 1-888-510-2154
International Toll Free (Germany): 498005889782

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Bricks & Mortar Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 203 current locations spanning British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and growing. In 2021, Canna Cabana became the first cannabis discount club retailer in the world.

Retail Innovation: Fastendr™ is a unique and fully automated technology that employs retail kiosks to facilitate a better buying experience through browsing, ordering and pickup.

Consumption Accessories: High Tide operates a suite of leading accessory e-commerce platforms across the world, including Grasscity.com, Smokecartel.com, Dailyhighclub.com, and Dankstop.com.

Brands: High Tide's industry-leading and consumer-facing brand roster includes Queen of Bud™, Cabana Cannabis Co™, Daily High Club™, Vodka Glass™, Puff Puff Pass™, Dopezilla™, Atomik™, Hue™, Evolution™ and more.

CBD: High Tide continues to cultivate the possibilities of consumer CBD through Nuleafnaturals.com, FABCBD.com, blessedcbd.de and blessedcbd.co.uk.

Wholesale Distribution: High Tide keeps that cannabis category stocked with wholesale solutions via Valiant™.

Licensing: High Tide continues to push cannabis culture forward through fresh partnerships and license agreements under the Famous Brandz™ name.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2024 for the fourth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.

CONTACT INFORMATION

Media Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee@hightideinc.com
403-770-3080

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: continued strength and momentum of the Company; the Company reporting record revenue, powerful sequential Adjusted EBITDA growth and an increase in same-store sales during the quarter; the results being above analyst expectations; the date and time of the release of the Company's third fiscal quarter ended July 31, 2025 results and their webcast and conference to discuss the results thereof; and the Company building the next global cannabis powerhouse. Readers are cautioned not to place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

CAUTIONARY NOTE REGARDING FUTURE ORIENTED FINANCIAL INFORMATION

This press release may contain future oriented financial information ("FOFI") within the meaning of applicable securities legislation about prospective results of operations, financial position or cash flows, which is subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above "Cautionary Note Regarding Forward-Looking Statements". FOFI is not presented in the format of a historical balance sheet, income statement or cash flow statement. FOFI does not purport to present the Company's financial condition in accordance with IFRS as issued by the International Accounting Standards Board, and there can be no assurance that the assumptions made in preparing the FOFI will prove accurate. The actual results of operations of the Company and the resulting financial results will likely vary from the amounts set forth in the analysis presented, and such variation maybe material (including due to the occurrence of unforeseen events occurring subsequent to the preparation of the FOFI). The Company and management believe that the FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments as of the applicable date. However, because this information is highly subjective and subject to numerous risks, readers are cautioned not to place undue reliance on the FOFI as necessarily indicative of future results. Except as required by applicable securities laws, the Company undertakes no obligation to update such FOFI. Importantly, the FOFI contained in this press release are, or may be, based upon certain additional assumptions that management believes to be reasonable based on the information currently available to management, including, but not limited to, assumptions about: (i) the future pricing for the Company's products, (ii) the future market demand and trends within the jurisdictions in which the Company may from time to time conduct the Company's business, (iii) the Company's ongoing inventory levels, and operating cost estimates, and (iv) the Company's net proceeds from the Company's current and future financings. The FOFI or financial outlook contained in this press release do not purport to present the Company's financial condition in accordance with IFRS as issued by the International Accounting Standards Board, and there can be no assurance that the assumptions made in preparing the FOFI will prove accurate. The actual results of operations of the Company and the resulting financial results will likely vary from the amounts set forth in the analysis presented in any such document, and such variation may be material (including due to the occurrence of unforeseen events occurring subsequent to the preparation of the FOFI). The Company and management believe that the FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments as at the applicable date. However, because this information is highly subjective and subject to numerous risks including the risks discussed under the heading above entitled "Cautionary Note Regarding Forward-Looking Statements" and under the heading" Risk Factors" in the Company's public disclosures, FOFI or financial outlook within this press release should not be relied on as necessarily indicative of future results.

Readers are cautioned not to place undue reliance on the FOFI, or financial outlook contained in this press release. Except as required by Canadian securities laws, the Company does not intend, and does not assume any obligation, to update such FOFI.

IMPORTANT INFORMATION REGARDING PRELIMINARY FINANCIAL RESULTS CITED

The preliminary estimated financial results and other data for the third fiscal quarter ended July 31, 2025 set forth above are forward-looking information, unaudited and subject to the completion of the Company's financial closing procedures. This data has been prepared by, and is the responsibility of, the Company's management. High Tide's independent registered public accounting firm, Davidson & Company LLP, Chartered Professional Accountants, does not express an opinion or any other form of assurance with respect to the preliminary estimated financial results. The Company currently expects that its final results will be consistent with the estimates set forth above, but such estimates are preliminary and High Tide's actual results of operations and other data could differ materially from these estimates due to the completion of final adjustments and other developments that may arise between now and the time such consolidated financial statements for the fiscal quarter ended July 31, 2025 are released.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-announces-preliminary-q3-2025-guidance-302531865.html

SOURCE High Tide Inc.

FAQ

What are High Tide's (HITI) Q3 2025 revenue projections?

High Tide expects revenue between $147-150 million, representing 7-9% sequential growth and 12-14% year-over-year growth, exceeding analyst consensus of $146 million.

How much Adjusted EBITDA does High Tide (HITI) expect in Q3 2025?

The company projects Adjusted EBITDA of $9.6-10.6 million, showing 19-31% sequential growth and up to 10% year-over-year increase, above analyst expectations of $8.4 million.

What is High Tide's (HITI) same-store sales growth for Q3 2025?

High Tide reported a 7.4% increase in same-store sales, marking its highest growth rate in two years.

When will High Tide (HITI) release its full Q3 2025 earnings report?

High Tide will release its full Q3 2025 results on September 15, 2025, after market close, with a conference call scheduled for September 16, 2025, at 11:30 AM ET.

How many retail locations does High Tide (HITI) currently operate?

High Tide operates 203 retail locations across Canada under its Canna Cabana brand, spanning British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario.
High Tide

NASDAQ:HITI

HITI Rankings

HITI Latest News

HITI Latest SEC Filings

HITI Stock Data

250.11M
69.58M
14.08%
7.75%
4.49%
Pharmaceutical Retailers
Healthcare
Link
Canada
Calgary